Gastric cancer (GC) is a leading cause of cancer-related deaths worldwide. The Tff1 knockout (KO) mouse model develops gastric lesions that include low-grade dysplasia (LGD), high-grade dysplasia (HGD), and adenocarcinomas. In this study, we used Affymetrix microarrays gene expression platforms for analysis of molecular signatures in the mouse stomach [Tff1-KO (LGD) and Tff1 wildtype (normal)] and human gastric cancer tissues and their adjacent normal tissue samples. Combined integrated bioinformatics analysis of mouse and human datasets indicated that 172 genes were consistently deregulated in both human gastric cancer samples and Tff1-KO LGD lesions (P < .05). Using Ingenuity pathway analysis, these genes mapped to important transcription networks that include MYC, STAT3, b-catenin, RELA, NFATC2, HIF1A, and ETS1 in both human and mouse. Further analysis demonstrated activation of FOXM1 and inhibition of TP53 transcription networks in human gastric cancers but not in Tff1-KO LGD lesions. Using real-time RT-PCR, we validated the deregulated expression of several genes (VCAM1, BGN, CLDN2, COL1A1, COL1A2, COL3A1, EpCAM, IFITM1, MMP9, MMP12, MMP14, PDGFRB, PLAU, and TIMP1) that map to altered transcription networks in both mouse and human gastric neoplasia. Our study demonstrates significant similarities in deregulated transcription networks in human gastric cancer and gastric tumorigenesis in the Tff1-KO mouse model. The data also suggest that activation of MYC, STAT3, RELA, and b-catenin transcription networks could be an early molecular step in gastric carcinogenesis.
low-grade dysplasia (LGD), high-grade dysplasia (HGD), and gastric adenocarcinoma. 7 Genetically engineered mouse models provide an excellent platform to study human diseases including cancer. 8 Although several molecular studies of GC have been reported, 9 there is a crucial need for molecular characterization of mouse models of this disease to assess their similarity to human GC and suitability for in vivo studies.
Studies of animal models can provide a better understanding of early changes in gastric tumorigenesis that can possibly improve our current diagnostic, prognostic, and possibly therapeutic approaches in GC.
Activation of WNT/b-catenin, MYC, and STAT transcription factors plays an important role in initiation and progression of several cancers. [10] [11] [12] [13] The role of b-catenin activation and cancer is best exemplified in the cascade of colon carcinogenesis. 14, 15 The aberrant activation of the Wnt/b-catenin signaling pathway has been described in 30%-60% of GC tissues and in GC cell lines. 11, [16] [17] [18] The conserved Wnt/b-Catenin pathway regulates stem cell pluripotency and cell fate decisions during development. 11 A recent study has suggested that Wnt/b-catenin signaling may be involved in the self-renewal of GC stem cells (GCSC). 12 The oncogenic MYC family encodes N-myc, cmyc, and L-myc transcription factors' proteins. 19 MYC plays a fundamental role in several cellular functions, including regulation of cell growth, proliferation, metabolism, differentiation, apoptosis, and angiogenesis. 20 , 21 MYC activation has been reported in different types of cancers that include GC. 10, 22, 23 Similar to MYC, the signal transducer and activator of transcription protein 3 (STAT3) participates in a series of tumorigenic processes including cell proliferation, cell survival, antiapoptosis, angiogenesis, drug resistance, immune evasion, and inflammation. 24, 25 STAT3 is constitutively activated in several human cancers including thyroid, lung, ovarian, breast, colon, and GC. 26, 27 Inhibition of STAT3 has antitumor effects in several human cancer models. 25, 28, 29 In this study, we investigated the aberrant gene expression signature and transcription networks in early dysplastic gastric lesions from mouse and human GC tissue samples. Using integrated bioinformatics analysis approaches, we identified similar molecular signatures and transcription networks in mouse and human neoplastic lesions. The observed similarities suggest that activation of these pathways could be an early step in initiation of gastric tumorigenesis. The results also denote that the Tff1 KO mouse is an excellent model for in vivo studies of molecular mechanisms in gastric tumorigenesis.
| MATERIALS A ND METHODS

| Mouse and human gastric tissue samples
In this study, we used gastric tissue samples from Tff1 KO and wildtype (WT) C57BL/6J/129/Svj mice. Tissue samples from the glandular antrum region of the stomach were collected from 4 Tff1 KO and 6
Tff1 WT mice of similar background and matching ages (Supporting Information 
| Gene expression microarray analysis
RNeasy mini kit (Qiagen, Germantown, MD) was used to isolate total
RNAs from antrum region of gastric mucosa of 10 Tff1 KO (LGD) and between Tff1 KO mice (n 5 4) and Tff1 WT mice (n 5 6) or between human GC samples (n 5 9) and human normal gastric tissues (n 5 9).
The raw gene expression data (.cel files) were preprocessed and normalized by using the robust multiarray average (RMA) expression measure, with RMA function in Bioconductor affy package (http://www.
bioconductor.org/packages/release/bioc/html/affy.html). 30 The expression values were in log2 format after RMA. 30 Bioconductor limma package was used for array data analysis (http://www.bioconductor.org/ packages/release/bioc/html/limma.html). 31 A linear model was fitted to the expression data for each probe. Moderated t statistics were computed by empirical Bayes shrinkage of the standard errors toward a common value. The P values corresponded to the moderated t statistics. Symbol, approved gene symbol; Fold change, relative gene expression fold change; P value, P value of .05 was considered significant; PFDR, positive false discovery rate; Cytoband, gene location on subregions of a chromosome; Gene Name, full name of the gene.
We used both P values as well as fold change to determine candidate probe list by requiring at least 1.5-fold change and P .05, using R soft- 
| Quantitative real-time RT-PCR validation of downstream target genes in mice and human gastric tissues
This analysis was performed using independent tissue samples from mice and human. Mouse glandular stomach tissue samples included 10
Tff1 WT, 10 Tff1 KO with LGD, and 9 Tff1 KO with HGD. The histology and age information are provided in Supporting Information Table   S1 . Deidentified human stomach tissue samples included 19 with normal histology and 22 showing GC (Supporting Information Table S2 ).
Total RNA was purified using the RNeasy mini kit (Qiagen). Total RNA 
| R E S U L T S 3.1 | Significant alterations in gene expression are detectable in mouse gastric LGD lesions
Analysis of gene expression data from mouse gastric LGD lesions, as compared to normal tissues, demonstrated significant deregulation of 395 genes, using cutoffs of ratio change 1.5 or 0.75 and P .01
(Supporting Information Table S4 ). Among 328 genes that were overexpressed, 13 genes exhibited a fold change greater than 10 in LGD lesions. These genes included matrix metallopeptidase 10 (Mmp10), Mmp13, Mmp3, chemokine (C-X-C motif) ligand 1 (Cxcl1), Cxcl2 inhibin beta-A (Inhba), and prostaglandin-endoperoxide synthase 2 (Ptgs2, also known as Cox2; Table 2 ). However, 67 genes were down-regulated in -13  ARG1,BCL3,CD9,CEBPB,CXCL3,CXCL6,DDIT3,FN1,FST,GLIPR1,  HIF1A,HK2,ICAM1,IGFBP5,IL13RA2,IL1B,IL1RN,MUC1,NFATC2,  PDIA4,PTGS2,PTPN2,SLFN12L,TIMP1,TNFSF11, -16  ACAT1,ACOT11,ALDH4A1,ANXA3,ARPC1B,AURKA,BCL2L1,BID,BNIP3,  BRCA1,BUB1,BUB1B,C2,CDC7,CDK4,CDKN3,CENPF,CHEK1,CKAP2,CKB,  CTSB,CXCL1,CYB5A,DNMT1,DSN1,EPHX1,EXO1,F2R,F5,FAT1,FOS,  FOXP3,GLUL,GNAI1,GPD1L,GPX1,GPX3,GSN,HBEGF,HMGB1,IDH2,IFI30,  IFI35,IGF1R,IGFBP2,IGFBP3,IL2RA,IPO9,KAT2B,KIF23,KIFC1,KPNA2,LIF,  LSS,MCM3,MCM6,MCM7,ME1,MMP9,NCAPG,NCAPH,NEK2,NFKB2,  NOTCH1,PARK2,PCCA,PML,PRC1,PTPN6,PYCARD,RBL1,RFC3,RPRM,  SERPINH1,SGK1,SH3BGRL2,SLC2A12,SLC6A6,SNX5,SPC25,STAT1,STMN1,  TAP1,TDO2,TMSB10/TMSB4X,TNFRSF10B,TNFRSF9,TOP2A,TPD52L1,  TPP1,TPX2,TYMS Upstream Regulator, the upstream regulator for the target genes in dataset. Predicted Activation State, signaling pathways' status predicted based on the downstream target gene expression levels. P value of overlap, this is the P value computed using Fisher's Exact Test. This P-value measures the significance of overlap between our gene set and genes that are regulated by a transcriptional regulator stored in the Ingenuity Knowledge Base. Target molecules in dataset, genes that are regulated by a transcription upstream regulator based on the Ingenuity Knowledge Base.
(PSCA), alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide (ADH7).
We also determined signaling pathways that are likely to be early (Table 4) . Of note, analysis of human GC samples data predicated activation of the same pathways, suggesting that they are required for initiation and early steps of gastric tumorigenesis (Table 5 ). In addition, human GCs also demonstrated activation of FOXM1 and inhibition of TP53 transcription networks (Table 5 and Supporting Information Figure S1 ). A representative diagram showing coactivated networks that include MYC, STAT3, and b-catenin signaling pathways in mouse LGD and human GC is shown in Figure 1 .
| qPCR validation of representative transcription network target genes
To confirm the observed consistent changes in gene expression in mouse and human, we selected 14 differentially expressed genes based on their known functions in gastric tumorigenesis (Table 6 ). Using qRT-PCR, we validated several MYC, STAT3, and b-catenin downstream target genes in both mouse and human gastric tissue samples. Our results indicated that Timp1, Epcam, Cldn2, Vcam1, Mmp9, Mmp12, Pdgfrb, Bgn, and Plau were significantly overexpressed in both mouse
LGD and HGD gastric tissue samples, as compared with normal gastric tissue samples (P < .05, Figure 2) . Notably, Mmp14 was significantly overexpressed only in mouse HGD tissues (P < .01), while Iftm1 was upregulated exclusively in mouse LGD tissues (P < .01). In addition, our data showed a nonsignificant trend of overexpression of Col1a1, Col1a2 and Col3a1 in LGD or HGD gastric tissue samples, as compared to normal gastric tissue samples (Figure 2 ). However, our data indicated that all 14 genes that we tested were significantly overexpressed in human GC tissues, as compared with normal gastric samples (P < .05, Figure 3 ). Of note, TFF1 mRNA expression level was significantly down-regulated in human GC tissue samples (Supporting Information Figure S2 ). Collectively, our results validate the microarray data and suggest that these validated genes are possibly involved in early stages of gastric tumorigenesis and their deregulated expression persists in advanced stages of GC.
| DISCUSSION
GC remains the third leading cause of cancer-associated death worldwide. 34 Although the incidence of distal GC is declining, 35 the incidence of proximal cancers that include gastric cardia and gastroesophageal junction continues to be on the rise. The late diagnosis of GC is a clinically challenging problem with low favorable response rates to current chemotherapeutics leading to poor prognosis and clinical outcome. 1 The use of genetic analysis of inbred mouse models of carcinogenesis has an important advantage of limited heterogeneity, therefore, allowing discovery of consistent genetic alterations that are related to the disease process. In addition, using mouse models offers an opportunity to overcome the difficulties associated with early diagnosis, procurement, and analysis of premalignant lesions in human.
In this study, we performed integrated bioinformatics analysis of mouse and human molecular signatures to determine genes that are likely early drivers of gastric carcinogenesis. Our previous studies indicated that the Tff1 KO mice exhibit histological changes in the pyloric antrum of the stomach, progressing from gastritis to LGD, to HGD, and ultimately to malignant adenocarcinoma that are similar to human gastric tumorigenesis. 7, 19 Of note, loss of TFF1 expression is one of the most frequent molecular alterations in human gastric tumorigenesis due to epigenetic inactivation, loss of heterozygosity, or transcriptional regulation. [3] [4] [5] [6] Herein, we analyzed early premalignant LGD gastric lesions in the Tff1 KO mouse model and compared the results to human GC samples to eliminate the complex genetic and host heterogeneity factors that are present in human, and to overcome difficulties in acquiring human premalignant tissue samples. We postulated that if a gene is seen in mouse LGD lesions as well as in human GC samples, this gene is likely an early event and a driver of the disease process.
Indeed, we have discovered several molecular similarities and validated several genes using mouse and human stomach tissues. For example,
we have confirmed overexpression of MMP9, MMP12, MMP14, and EPCAM in both mouse and human. These genes play an important role in cellular invasion. 36 We have also confirmed the overexpression of CLDN2 and PDGFRB, which are known to promote cellular transformation and survival. 37, 38 It is worth mentioning, our data have shown a progressive increase in expression level of several genes from LGD to Examples of consistently deregulated genes in both human GC and Tff1 KO mouse LGD tissue samples, as compared with normal gastric tissue samples are rare in GC, 18 non-mutational activation of b-catenin/TCF transcription network is common in GC. 41 b-catenin can also be activated by AKT signaling pathway, which is predominantly active in GC. 42 Furthermore, we and others have shown that molecular factors that inhibit GSK3b and PP2A activities play a role in activation of b-catenin in GC. 42, 43 In addition, regulation of b-catenin by miRNAs has been described in GC. 44 b-catenin is an essential transcription network that regulates a wide spectrum of transcription target genes that control important cellular functions such as adhesion, proliferation, angiogenesis, and invasion. 11 It has also been suggested that b-catenin could play a role in regulating GCSC and progenitor stem cells capacity. MYC is one of the most recognized transcription factors in biological processes that regulate numerous oncogenic functions in GC. 21 Although MYC overexpression alone is incapable of inducing neoplastic transformation of normal human cells, 46, 47 it is recognized as a potent oncogene that promotes tumor development and progression. 48 We have found activation of MYC transcription network in LGD of mouse and human GC samples suggesting its importance in early stages of gastric tumorigenesis. This is particularly important given its known significant role in regulating cellular stemness, proliferation, and angiogenesis in cancer. 21 Taken together, our findings suggest that activation of MYC transcription network is possibly another crucial early molecular event in gastric carcinogenesis.
Of note, we also detected activation of STAT3 transcription network in both mouse and human neoplastic gastric lesions. STAT3 is constitutively activated in several gastrointestinal malignancies that include colon cancer and GC. 49, 50 We have previously shown that Our data also suggested activation of NFATC2, HIF1A, and ETS1
in human GC and early stages of tumorigenesis in the Tff1 KO mice.
NFATC2 plays an important role in regulating the development of cancer related inflammation, promoting colon cancer cell differentiation, and proliferation. 54 HIF1A is a master regulator of cell response to hypoxia by activating genes involved in angiogenesis, apoptosis, and energy metabolism. [55] [56] [57] HIF1A expression has been recently reported in various human cancers including pancreatic cancer, esophageal cancer and breast cancer, promoting cancer angiogenesis, proliferation, and survival. [57] [58] [59] Similarly, activation of ETS1, a member of the ETS family of transcription factors, is known to be involved in cancer progression in breast cancer, pancreatic cancer, prostate cancer, and GC. [60] [61] [62] [63] Recent studies suggested that ETS1 expression is linked to the cancers with higher invasive, angiogenic activity. 60 The fact that we identified activation of these networks in LGD lesions of the Tff1 KO mouse imply that these transcription factors are not only involved in late stages of cancer but also possibly in early stages of initiation of gastric tumorigenesis.
We also detected transcription networks that were deregulated in human advanced GC but not in mouse LGD lesions. These included inactivation of TP53 and activation of FOXM1. Inactivation of p53 is caused by mutations in more than half of human cancers. 64 Mutant p53 provides cancer cells gain-of-function properties, such as increased cell proliferation, metastasis and apoptosis resistance. 64 Recent studies suggest that loss of p53 or the accumulation of mutant p53 were observed more in poorly-differentiated than in well-differentiated gastric carcinomas. 65 The accumulation of p53 in immunohistochemical staining, an indicator of mutation of p53, was also significantly higher in large, advanced, and metastatic GCs. 66 However, FOXM1 plays a key role in tumor progression as noted in recent studies showing that cancer cell proliferation and tumor growth are significantly reduced when FOXM1 is deleted. 67, 68 In pancreatic cancer, matrix metalloproteinases (MMPs) were regulated by FOXM1, increasing cancer cell migration and invasion. 68 Of note, FOXM1 expression in cancer cells can promote activation of DNA damage repair networks and confer resistance to chemotherapeutics. 69 Collectively, these findings from earlier reports can explain the lack of inactivation of p53 and activation of FOXM1 in early neoplastic gastric lesions in the Tff1 KO mouse model. Although our analysis and interpretation have focused on consistent changes between mouse LGD and human cancer, there were also examples of genes that did not overlap. A possible explanation of this apparent discrepancy may be attributed to the conserved nature of gene expression among different species (mouse and human). Alternatively, it is also plausible that some of these changes could be related to advanced stages of GC rather than early stages of tumorigenesis.
In conclusion, our study provided a comprehensive integrated molecular analysis of transcription networks in human and mouse models of GC. Our pilot data demonstrate that this is a powerful approach to study the molecular events and identify striking similarities such as activation of b-catenin, MYC, and STAT3 transcription networks. We acknowledge the limitations in our study due to lack of human dysplastic lesions. Nevertheless, our findings highlight the important role of mouse models of GC that provide an opportunity to overcome some of the inherent limitations in human studies. 
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